Trademark Search in Canada

MISCELLANEOUS LOGO

View On IC.GC.CA

REGISTERED

on 21 May 2020

Last Applicant/ Owned by

AMGEN INC.

One Amgen Center DriveThousand Oaks, CA 91320-1799

Serial Number

1859047 filed on 22^nd Sept 2017

Registration Number

TMA1078769 registered on 21^st May 2020

Registration expiry Date

21^st May 2030

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

M5H3Y2

MISCELLANEOUS LOGO

Trademark usage description

pharmaceutical preparations for use in the treatment of tumorous diseases; b-cell disorders, namely leukemia, lymphoma, multiple myeloma, humoral immu Read More

Vienna Information

24 . 15 . 21

Arrowheads -- Note: Not including arrowheads in the form of angles (26.3.23).Pointes de flèches -- Note: Non compris les pointes de flèches en forme d'angles (26.3.23).

26 . 3 . 4

Several triangles, juxtaposed, joined or intersectingPlusieurs triangles, juxtaposés, accolés ou se coupant

26 . 3 . 7

Triangular figures with one or more truncated or rounded anglesFigures triangulaires à un ou plusieurs angles coupés ou arrondis

26 . 3 . 24

Triangles with dark surfaces or parts of surfacesTriangles avec surface ou partie de la surface foncée

26 . 1 . 2

EllipsesEllipses

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

Classification Information

Class [005]
Pharmaceutical preparations for use in the treatment of tumorous diseases; B-cell disorders, namely leukemia, lymphoma, multiple myeloma, humoral immune deficiency, and plasma cell proliferative disease; autoimmune diseases; inflammation, namely asthma, celiac disease, prostatitis, colitis, diverticulitis, glomerulonephritis, hidradenitis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, cystitis, mast cell activation syndrome, mastocytosis, otitis, sarcoidosis, transplant rejection, and vasculitis; infectious diseases, namely urinary tract infection, skin infection, respiratory tract infection, odontogenic infection, vaginal infection, and amniotic infection; and minimal residual disease, namely cancer cells from bone marrow.

Classification kind code

Mark Details

Serial Number

1859047

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 190 on 11^th Dec 2019	Registration Pending
Submitted for opposition 42 on 18^th Sept 2019	Advertised
Submitted for opposition 26 on 28^th Aug 2019	Approved
Submitted for opposition 27 on 28^th Aug 2019	Approval Notice Sent
Submitted for opposition 15 on 5^th Feb 2019	Correspondence Created
Submitted for opposition 22 on 18^th Oct 2018	Search Recorded
Submitted for opposition 20 on 18^th Oct 2018	Examiner's First Report
Submitted for opposition 31 on 26^th Sept 2017	Formalized
Submitted for opposition 1 on 25^th Sept 2017	Created
Submitted for opposition 30 on 22^nd Sept 2017	Filed